222 related articles for article (PubMed ID: 16026985)
1. Current approaches to management of depression in Parkinson's Disease.
Vajda FJ; Solinas C
J Clin Neurosci; 2005 Sep; 12(7):739-43. PubMed ID: 16026985
[TBL] [Abstract][Full Text] [Related]
2. Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.
Arbouw ME; Movig KL; Neef C; Guchelaar HJ; Egberts TC
Eur J Clin Pharmacol; 2007 Feb; 63(2):181-7. PubMed ID: 17200834
[TBL] [Abstract][Full Text] [Related]
3. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
Thorkelson G; Bielefeldt K; Szigethy E
Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.
Liu J; Dong J; Wang L; Su Y; Yan P; Sun S
PLoS One; 2013; 8(10):e76651. PubMed ID: 24098546
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
6. Depression in patients with Parkinson's disease.
Cummings JL; Masterman DL
Int J Geriatr Psychiatry; 1999 Sep; 14(9):711-8. PubMed ID: 10479741
[TBL] [Abstract][Full Text] [Related]
7. The place for the tricyclic antidepressants in the treatment of depression.
Boyce P; Judd F
Aust N Z J Psychiatry; 1999 Jun; 33(3):323-7. PubMed ID: 10442787
[TBL] [Abstract][Full Text] [Related]
8. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of paroxetine in Parkinson's disease: a prospective study.
Tesei S; Antonini A; Canesi M; Zecchinelli A; Mariani CB; Pezzoli G
Mov Disord; 2000 Sep; 15(5):986-9. PubMed ID: 11009210
[TBL] [Abstract][Full Text] [Related]
10. Does the use of SSRIs reduce medical care utilization and expenditures?
Chung S
J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
[TBL] [Abstract][Full Text] [Related]
12. Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.
van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
Br J Clin Pharmacol; 2002 Aug; 54(2):168-70. PubMed ID: 12207636
[TBL] [Abstract][Full Text] [Related]
13. Depression in Parkinson's disease. Pharmacological characteristics and treatment.
Tom T; Cummings JL
Drugs Aging; 1998 Jan; 12(1):55-74. PubMed ID: 9467687
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
Hirschfeld RM
J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.
Mills KA; Greene MC; Dezube R; Goodson C; Karmarkar T; Pontone GM
Int J Geriatr Psychiatry; 2018 Apr; 33(4):642-651. PubMed ID: 29235150
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
20. New antidepressants in the treatment of neuropathic pain. A review.
Mattia C; Paoletti F; Coluzzi F; Boanelli A
Minerva Anestesiol; 2002 Mar; 68(3):105-14. PubMed ID: 11981519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
